Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G M Tyce

Showing results (141-150 of 159) with videos related to

Pageof 16
Sort By:
Circulation|December 1, 1991
Catecholamine metabolic pathways and exercise training. Plasma and urine catecholamines, metabolic enzymes, and chromogranin-AP J Rogers, G M Tyce, R M Weinshilboum, et al.
Federation Proceedings|July 1, 1986
Amine sulfate formation in the central nervous systemG M Tyce, J M Messick, T L Yaksh, et al.
Neurology|March 1, 1996
Levodopa and deprenyl treatment effects on peripheral indices of oxidant stress in Parkinson's diseaseJ E Ahlskog, R J Uitti, P A Low, et al.
Advances in Pharmacology (San Diego, Calif.)|November 5, 1997
The adrenal gland as a source of dihydroxyphenylalanine and catecholamine metabolitesG M Tyce, S L Chritton, R D Barnes, et al.
The Journal of Laboratory and Clinical Medicine|December 14, 1999
Dopamine enhances the phosphaturic effect of PTH during acute respiratory alkalosisT J Berndt, R R Tucker, P D Kent, et al.
Neuroscience|July 18, 2001
Nitric oxide modulates evoked catecholamine release from canine adrenal medullaR D Barnes, L E Ward, K P Frank, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|August 5, 2003
L-DOPA biotransformation: correlations of dosage, erythrocyte catechol O-methyltransferase and platelet SULT1A3 activities with metabolic pathways in Parkinsonian patientsM K Dousa, R M Weinshilboum, M D Muenter, et al.
Experimental Neurology|October 1, 1991
Decreased levels of [Met]enkephalin, neuropeptide Y, substance P, and vasoactive intestinal peptide in parkinsonian adrenal medullaS L Stoddard, G M Tyce, J E Ahlskog, et al.
Experimental Neurology|August 1, 1989
Cerebrospinal fluid indices of blood-brain barrier permeability following adrenal-brain transplantation in patients with Parkinson's diseaseJ E Ahlskog, G M Tyce, P J Kelly, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 1, 1995
No evidence for systemic oxidant stress in Parkinson's or Alzheimer's diseaseJ E Ahlskog, R J Uitti, P A Low, et al.
Pageof 16

Showing results (141-150 of 159) with videos related to

Sort By:
Pageof 16
Circulation|December 1, 1991
Catecholamine metabolic pathways and exercise training. Plasma and urine catecholamines, metabolic enzymes, and chromogranin-AP J Rogers, G M Tyce, R M Weinshilboum, et al.
Federation Proceedings|July 1, 1986
Amine sulfate formation in the central nervous systemG M Tyce, J M Messick, T L Yaksh, et al.
Neurology|March 1, 1996
Levodopa and deprenyl treatment effects on peripheral indices of oxidant stress in Parkinson's diseaseJ E Ahlskog, R J Uitti, P A Low, et al.
Advances in Pharmacology (San Diego, Calif.)|November 5, 1997
The adrenal gland as a source of dihydroxyphenylalanine and catecholamine metabolitesG M Tyce, S L Chritton, R D Barnes, et al.
The Journal of Laboratory and Clinical Medicine|December 14, 1999
Dopamine enhances the phosphaturic effect of PTH during acute respiratory alkalosisT J Berndt, R R Tucker, P D Kent, et al.
Neuroscience|July 18, 2001
Nitric oxide modulates evoked catecholamine release from canine adrenal medullaR D Barnes, L E Ward, K P Frank, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|August 5, 2003
L-DOPA biotransformation: correlations of dosage, erythrocyte catechol O-methyltransferase and platelet SULT1A3 activities with metabolic pathways in Parkinsonian patientsM K Dousa, R M Weinshilboum, M D Muenter, et al.
Experimental Neurology|October 1, 1991
Decreased levels of [Met]enkephalin, neuropeptide Y, substance P, and vasoactive intestinal peptide in parkinsonian adrenal medullaS L Stoddard, G M Tyce, J E Ahlskog, et al.
Experimental Neurology|August 1, 1989
Cerebrospinal fluid indices of blood-brain barrier permeability following adrenal-brain transplantation in patients with Parkinson's diseaseJ E Ahlskog, G M Tyce, P J Kelly, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 1, 1995
No evidence for systemic oxidant stress in Parkinson's or Alzheimer's diseaseJ E Ahlskog, R J Uitti, P A Low, et al.
Pageof 16